REFERENCES
- Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. CMAJ. 2008;178:1005–1011.
- Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66:848–856.
- Gallagher RP. National Survey of Counseling Center Directors. Pittsburgh, PA: The International Association of Counseling Services; 2010.
- Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatry. 2002;180:104–109.
- Bullock A, Patten C. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Epidemiol. 2010;45:47–56.
- Canadian Community Health Survey: Mental Health and Well-Being. Available at: http://www.statcan.gc.ca/pub/82-617-x/index-eng.htm. Published 2002. Accessed May 2, 2013.
- Cooper C, Bebbington P, King M. Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey. Acta Psychiatry Scand. 2007;116:47–53.
- Krishna S, Austin Boren S, Ballas E. Healthcare via cellphones: a systematic review. Telemed J E Health. 2009;15:231–240.
- Weingarten S, Henning J, Badamgarav E, et al. Interventions used in disease management programmes for patients with chronic illness—which ones work? Meta-analysis of published reports. BMJ. 2002;325:1–8.
- Sahm L, MacCurtain A, Hayden J, Roche C, Richards H. Electronic reminders to improve medication adherence—are they acceptable to the patient? Pharmacol World Sci. 2009;31:627–629.
- National Quality Forum. National Voluntary Consensus Standards for Ambulatory Care: An Initial Physician-Focused Performance Measure Set. Washington, DC: National Quality Forum; 2006.
- Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100.
- Russel DW. UCLA Loneliness Scale (version 3): reliability, validity, and factor structure. J Pers Assess. 1996;66:20–40.
- Cohen S, Hoberman HM. Positive events and social supports as buffers of life change. J Appl Soc Psychol. 1983;13:99–125.
- Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–396.
- Christensen AJ, Moran PJ, Wiebe JS. Assessment of irrational health beliefs: relation to health practices and medical regimen adherence. Health Psychol. 1999;18:169–176.
- Mojtabai R. Americans’ attitude toward mental health treatment seeking: 1990–2003. Psychiatr Serv. 2007;58:642–651.
- McCann T, Boardman G, Clark E, Lu S. Risk profiles for non-adherence to antipsychotic medications. J Psychiatr Ment Health Nurs. 2008;15:622–629.
- Novick D, Haro J, Suarez D, Perez V, Dittman R, Haddad P. Predictors and clinical consequences of non-adherence with antipsychotic medications in the outpatient treatment of schizophrenia. Psychiatry Res. 2010;176:109–113.
- Gebo K, Keruly J, Moore R. Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. J Gen Intern Med. 2003;18:104–111.
- Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regime on non-adherence to HIV treatment. AIDS Care. 2004;16:199–211.
- Hicks P, Mulvey K, Changer G, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care. 2007;19:1124–1140.
- Malta M, Strathdee S, Magnanini M, Bastos F. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103:1242–1257.